Evaluating the mental health effects of COVID-19 on MD Anderson employees
Official title: Psychosocial Impact of COVID-19 Pandemic on MD Anderson Workforce
Run by M.D. Anderson Cancer Center · NCT04491292 · Data updated 2026-11-12
This study looks at how the COVID-19 pandemic has affected the mental health of MD Anderson employees to see what support they might need.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 20000 (estimated) |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Status | Recruiting |
| Started | May 18, 2020 |
| Main results expected | April 30, 2028 |
| Study ends | April 30, 2028 |
| Registry record updated | July 22, 2026 |
| Trial ID | NCT04491292 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are employees of MD Anderson Cancer Center.
✕Probably not a fit
Patients who are not employees of MD Anderson Cancer Center will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study examines the psychosocial impact of the COVID-19 pandemic on the workforce at MD Anderson Cancer Center. It aims to assess stress-related outcomes among employees during and after the pandemic through two online questionnaires administered at baseline and three months post-pandemic. The study also seeks to identify demographic and occupational factors that may influence these psychosocial outcomes, allowing for targeted mental health support for staff. By understanding these impacts, the institution can implement more effective measures to safeguard employee well-being.
Why it matters
Potential benefit: If successful, this study could lead to improved mental health support and resources for healthcare workers affected by the pandemic.
How similar studies have gone: Other studies have shown that understanding the psychosocial effects of pandemics on healthcare workers can lead to effective interventions, indicating that this approach is supported by prior research.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * MD Anderson employees
Where it's running
-
M D Anderson Cancer Center
Houston, Texas, United States Recruiting
Study contacts
- Principal investigator: Priya R Bhosale — M.D. Anderson Cancer Center
- Study coordinator: Priya R. Bhosale
- Email: priya.bhosale@mdanderson.org
- Phone: 713-792-0221
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ibuzatrelvir alone or with remdesivir for severely immunocompromised adults with COVID-19
This will test whether ibuzatrelvir, taken alone or together with remdesivir, helps severely immunocompromised adults who recently developed COVID-19 symptoms.
-
Next generation inhaled COVID-19 vaccine
This study is testing a new inhaled COVID-19 vaccine to see if it is safe and can boost the immune response in people who have already had at least three doses of an mRNA COVID vaccine.
-
Evaluating COVID-19 immunity and reinfection risk
This study is testing how well COVID-19 vaccines and previous infections protect medical staff from getting reinfected with the virus over 48 weeks.
-
Understanding the benefits of human milk on infant and child health
This study is trying to see how breast milk affects the health of babies and children by collecting milk samples and health information from breastfeeding mothers.
-
Examining how COVID-19 changed pulmonary procedures
This study looks at how doctors who treat lung conditions changed their procedures and staffing during the COVID-19 pandemic to see what worked best.
-
Analyzing immune responses to COVID-19 through sample collection
This study is testing how the immune system reacts to COVID-19 by collecting samples from people who have had the virus and those who haven't, to see what this means for their health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.